Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

Detection of minimal residual disease in pediatric acute lymphoblastic leukemia

(2013) Giuseppe Gaipa et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

(2013) Andy C. Rawstron et al.   JOURNAL OF CLINICAL ONCOLOGY

viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

(2013) El-ad David Amir et al.   NATURE BIOTECHNOLOGY

Critical assessment of automated flow cytometry data analysis techniques

(2013) Nima Aghaeepour et al.   NATURE METHODS

Cytometry: Today’s technology and tomorrow’s horizons

(2012) Pratip K. Chattopadhyay et al.   METHODS

New markers for minimal residual disease detection in acute lymphoblastic leukemia

(2011) E. Coustan-Smith et al.   BLOOD

Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data

(2011) Karel Fišer et al.   CYTOMETRY PART A

Improved compensation of the fluorochrome AmCyan using cellular controls

(2011) Joseph A. DiGiuseppe et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum

(2011) S. C. Bendall et al.   SCIENCE

Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testing

(2010) Elaine Coustan-Smith et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia

(2010) Drorit Luria et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;

(2009) J. Irving et al.   HAEMATOLOGICA

Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow

(2009) Giuseppe Basso et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry

(2009) Ester Mejstříková et al.   PEDIATRIC BLOOD & CANCER

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

(2008) M. J. Borowitz et al.   BLOOD

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

(2008) Michael Norbert Dworzak et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells

(2008) Giuseppe Gaipa et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: Potential usefulness in minimal residual disease detection

(2008) Joseph A. DiGiuseppe et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

A chromatic explosion: the development and future of multiparameter flow cytometry

(2008) Pratip K. Chattopadhyay et al.   IMMUNOLOGY